TACRINE HYDROCHLORIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for tacrine hydrochloride and what is the scope of patent protection?

Tacrine hydrochloride is the generic ingredient in one branded drug marketed by Shionogi Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for tacrine hydrochloride.

Summary for TACRINE HYDROCHLORIDE

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	2
Raw Ingredient (Bulk) Api Vendors:	93
Clinical Trials:	5
Patent Applications:	3,781
DailyMed Link:	TACRINE HYDROCHLORIDE at DailyMed

Recent Clinical Trials for TACRINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Midwest Biomedical Research Foundation	Phase 2
National Institute on Drug Abuse (NIDA)	Phase 2
Forest Laboratories	Phase 4

See all TACRINE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for TACRINE HYDROCHLORIDE

Cholinesterase Inhibitors
Nootropic Agents
Parasympathomimetics

Anatomical Therapeutic Chemical (ATC) Classes for TACRINE HYDROCHLORIDE

N06DA	Anticholinesterases
N06D	ANTI-DEMENTIA DRUGS
N06	PSYCHOANALEPTICS
N	Nervous system

US Patents and Regulatory Information for TACRINE HYDROCHLORIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Shionogi Inc	COGNEX	tacrine hydrochloride	CAPSULE;ORAL	020070-002	Sep 9, 1993		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Shionogi Inc	COGNEX	tacrine hydrochloride	CAPSULE;ORAL	020070-003	Sep 9, 1993		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Shionogi Inc	COGNEX	tacrine hydrochloride	CAPSULE;ORAL	020070-001	Sep 9, 1993		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Shionogi Inc	COGNEX	tacrine hydrochloride	CAPSULE;ORAL	020070-004	Sep 9, 1993		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TACRINE HYDROCHLORIDE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Shionogi Inc	COGNEX	tacrine hydrochloride	CAPSULE;ORAL	020070-002	Sep 9, 1993	⤷ Sign Up	⤷ Sign Up
Shionogi Inc	COGNEX	tacrine hydrochloride	CAPSULE;ORAL	020070-001	Sep 9, 1993	⤷ Sign Up	⤷ Sign Up
Shionogi Inc	COGNEX	tacrine hydrochloride	CAPSULE;ORAL	020070-004	Sep 9, 1993	⤷ Sign Up	⤷ Sign Up
Shionogi Inc	COGNEX	tacrine hydrochloride	CAPSULE;ORAL	020070-002	Sep 9, 1993	⤷ Sign Up	⤷ Sign Up
Shionogi Inc	COGNEX	tacrine hydrochloride	CAPSULE;ORAL	020070-003	Sep 9, 1993	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.